US › Healthcare

Optimi Health Corp. Common Shares (OPTH)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$4.96+1.22%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$98,700

Revenue YoY

-49.7%

Net profit

$-1.7M

EPS

$-0.40

EPS estimate

$-0.26

Net margin

-1,715.0%

EPS came in at -0.40 against a street estimate of -0.26 — a miss of 53.8%.

Key statistics

Market cap

$25.3M

Forward P/E

0.0

P/B

2.00

Book value

$2.23

EPS (TTM)

$-1.46

52-week high

$8.84

52-week low

$4.00

50-day MA

$4.77

200-day MA

$4.85

Beta

1.59

Shareholding

Insiders

12.66%

Institutions

7.75%

Largest institutional holders

Fund	Stake
Yorkville Advisors Global, LP	3.48%
AdvisorShares Investments, LLC	1.80%
NATIONAL BANK OF CANADA /FI/	0.01%
SRS Capital Advisors Inc	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Optimi Health Corp. Common Shares — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.